7 results
RIPE Therapy - Drug Regimens for Microbiologically Confirmed Pulmonary Tuberculosis - IDSA Guidelines

#Tuberculosis #ActiveTB #RIPE #Therapy
RIPE Therapy - Drug ... Microbiologically Confirmed Pulmonary ... #Tuberculosis #ActiveTB ... Therapy #regimens #medications ... #Guidelines #Treatment
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
inhibitors • Injection drug ... Active TB: • ... : Active TB: • ... #Diagnosis #Management ... #Treatment #ActiveTB
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
inhibitors • Injection drug ... Active TB: • ... : Active TB: • ... #Diagnosis #Management ... #Treatment #ActiveTB
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
IDSA Recommendations ... disease) Indications ... no evidence of active ... and molecular diagnostic ... #IDSA #Prevention
Immune Reconstitution Inflammatory Syndrome - Overview of IRIS

What Is IRIS?
	• A state of hyperinflammatory response that
, pulmonary infiltrates ... lymphadenitis, pulmonary ... , hypoxia, and pulmonary ... • Persistently active ... infection/drug
Causes of Lactate Elevation, Lactic Acidosis - Differential Diagnosis

The most common causes of hyperlactatemia are usually:
circulation If drugs ... before beginning treatment ... output - Acute pulmonary ... Alcohol • Type B2: Drugs ... - HIV/HAART medications
IDSA Recommendations for Preventing and Treating Disseminated Mycobacterium Avium Complex in HIV-AIDS
Preventing 1st Episode of Disseminated
IDSA Recommendations ... Prophylaxis): Indications ... Note: Active TB ... AviumComplex #MAC #IDSA ... #Prevention #Treatment